Wealthfront Corporation

The company went public on the Nasdaq under the ticker WLTH

Wealthfront IPO: Shares of major robo-advisory platform become available

Oracle Corporation

Adobe Inc.

Photronics, Inc.

Marvell Technology, Inc.

Daily review and forecast of events on the U.S. stock market from Mikhail Denislamov, Deputy Director of Freedom Capital Markets Research.

New York Morning: Oracle may wake up the "bears"

Lumexa

The company goes public on the Nasdaq under the ticker LMRI

Lumexa IPO: trading in securities of the network of diagnostic imaging centers has started 

Cardinal Infrastructure Group Inc. Class A Common Stock

The company went public on the Nasdaq under the ticker CDNL

Cardinal IPO: shares in a comprehensive infrastructure services provider become available

Robert McCooey, vice chairman of the Nasdaq exchange, believes novice investors should look to the Nasdaq-100 index as a more balanced alternative to buying individual securities.

"Investing is not trading for 5 minutes": what does the Nasdaq deputy chairman advise newbies?

NVIDIA Corporation

Carvana Co.

Netflix, Inc.

Warner Bros. Discovery, Inc.

Paramount Skydance Corporation

CoreWeave, Inc.

The Gap, Inc.

Morning in New York: employment statistics will set the vector for trades

VolitionRx Limited

Shares of VolitionRx, a micro cap developer of blood-drop tests for cancer and sepsis, <a href="https://finance.yahoo.com/quote/VNRX/">jumped</a>&nbsp;9.5% yesterday, December 4. The company <a href="https://ir.volition.com/news-events/press-releases/detail/860/volitionrx-limited-announces-the-first-sale-of-the-nu-q-cancer-assays-for-clinical-certification-in-preparation-for-routine-clinical-use">reported</a>&nbsp;that France has selected its sepsis test for early disease detection in hospitals. Overall, Wall Street <a href="https://www.marketwatch.com/investing/stock/vnrx/analystestimates?mod=mw_quote_tab">believes</a>&nbsp;VolitionRx shares still have 730% upside.

Epigenetics co. VolitionRx climbs 10% on sepsis assay news, still offers 730% upside

Freedom Holdings Corp.

AI technologies cannot solve all business problems if the rest of the project infrastructure is not in place. This was the view expressed by Timur Turlov, founder of Freedom Holding, at the Financial Times Global Banking Summit in London.

"You can't just be in the AI business." Freedom Holding founder on business priorities

HP Inc.

Urban Outfitters, Inc.

Dell Technologies Inc.

Novo Nordisk A/S

Alphabet Inc.

Morning in New York: buyers are back in the majority

Olema Pharmaceuticals, Inc.

Roche Holding AG

Shares of Olema Pharmaceuticals, a small-cap maker of cancer drugs, <a href="https://finance.yahoo.com/quote/OLMA/">soared</a>&nbsp;almost 200% last week, November 18-24. Investors were <a href="https://www.roche.com/media/releases/med-cor-2025-11-18">reacting</a>&nbsp;to positive news on clinical trials from Swiss pharma giant Roche. Olema is advancing a therapy with a similar mechanism of action, meaning Roche’s success has reduced the perceived risks of investing in Olema, Freedom Broker explains. Against this backdrop, at least two Wall Street analysts have <a href="https://finance.yahoo.com/quote/OLMA/">raised</a>&nbsp;their target price on Olema shares.

Oncology drugmaker Olema triples in a week after latest Roche data eases sector risks

Alico, Inc.

Blue Bird Corporation

The shortened trading week looks unlikely to deliver major corporate events, with investors instead turning their attention to the final wave of quarterly earnings, September retail sales data, and the latest consumer confidence figures. Nevertheless, below is a look at what will be important in the small-cap universe this week, November 24-28.

This week for small caps: Blue Bird and Alico report amid shifting Fed expectations

Veeva Systems Inc.

Elastic N.V.

A morning in New York: waiting for the moment of truth